
Search ReportLinker
The Largest Collection of Market Research Reports
From +200,000 authoritative sources
... Technology platforms in order to deliver drugs. They have a strong research and development department with a number of potentially high-value therapeutics in area including oncology, pain, anti-infective ...
... Response letter. As a result of its acquisition of king, pfizer has assumed the development and commercialization rights and obligations to remoxy and to the three other licensed oradur-based opioid drug ...
... Proprietary intravenous formulation of acetaminophen, is indicated for the management of mild to moderate pain, the management of moderate to severe pain with adjunctive opioid analgesics, and the reduction ...
This report provides data on the therapeutic development for Opium (Opioid) Addiction, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players ...
Summary Acura Pharmaceuticals, Inc. (Acura) is a specialty pharmaceutical company. It researches, develops, manufactures and commercializes products for the treatment of severe pain using its proprietary ...
This report provides data on the therapeutic development for Chronic Pain, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved ...
Reportlinker.com © Copyright 2013. All rights reserved.